PMID- 10648640 OWN - NLM STAT- MEDLINE DCOM- 20000302 LR - 20141120 IS - 0026-895X (Print) IS - 0026-895X (Linking) VI - 57 IP - 2 DP - 2000 Feb TI - Photoaffinity labeling and purification of ZG-16p, a high-affinity dihydropyridine binding protein of rat pancreatic zymogen granule membranes that regulates a K(+)-selective conductance. PG - 308-16 AB - In rat pancreatic zymogen granules (ZG), an ATP-sensitive K(+) conductance and a Cl(-) conductance have been characterized that are inversely regulated by an approximately 65-kDa multidrug resistance P-glycoprotein (mdr1) gene product. In search of a label for purification of this protein, we found that the dihydropyridine derivative (-)-[(3)H]BZDC-DHP, a recently developed high-affinity ligand for Mdr1, binds with similar affinity to ZG membranes (ZGM) (K(d) = 6.2 nM). Binding was inhibited by nanomolar concentrations of the L-type Ca(2+) channel blockers azidopine and verapamil and by micromolar concentrations of the K(+) channel blockers glibenclamide and quinidine. Inhibition by glibenclamide was noncompetitive. The Mdr1 modulators cyclosporin A and vinblastine did not inhibit binding, which is different from Mdr1. In addition, only (+/-)-BZDC-DHP, azidopine, and verapamil selectively inhibited the K(+) conductance in ZGs, whereas the Cl(-) conductance was not affected. In photoaffinity labeling experiments, (-)-[(3)H]BZDC-DHP surprisingly specifically and selectively labeled a approximately 19-kDa protein in ZGM with a pharmacological profile identical with the high-affinity binding site but did not label a 65-kDa protein. The 19-kDa protein was purified by ion exchange chromatography and SDS-polyacrylamide gel electrophoresis and sequenced. The sequence obtained corresponds to ZG-16p, a recently cloned ZG protein with no apparent homology to Mdr1. The identity of the 19-kDa protein was confirmed by immunoprecipitation of (-)-[(3)H]BZDC-DHP-labeled ZGM with an anti-ZG-16p antibody. Furthermore, it is shown that ZG-16p is associated with the ZGM. We propose that ZG-16p, as part of the submembranous granule matrix, regulates the ATP-sensitive K(+) conductance of ZGs. FAU - Braun, M AU - Braun M AD - II. Department of Physiology, Medical Faculty, University of Saarland, Homburg/Saar, Germany. FAU - Thevenod, F AU - Thevenod F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Mol Pharmacol JT - Molecular pharmacology JID - 0035623 RN - 0 (2,6-dimethyl-4-(2-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid (2-(3-(4-benzoylphenyl)propionylamino)ethyl) ester ethyl ester) RN - 0 (Affinity Labels) RN - 0 (Benzophenones) RN - 0 (Dihydropyridines) RN - 0 (Enzyme Precursors) RN - 0 (Lectins) RN - 0 (Photosensitizing Agents) RN - 0 (Potassium Channel Blockers) RN - 0 (ZG16 protein, rat) RN - 7M8K3P6I89 (1,4-dihydropyridine) RN - 8L70Q75FXE (Adenosine Triphosphate) SB - IM MH - Adenosine Triphosphate/metabolism MH - Affinity Labels MH - Animals MH - Benzophenones/pharmacology MH - Binding Sites MH - Dihydropyridines/metabolism/pharmacology MH - Enzyme Precursors/*isolation & purification/metabolism MH - In Vitro Techniques MH - Lectins/*isolation & purification/metabolism MH - Male MH - Pancreas/enzymology/*metabolism MH - Photosensitizing Agents/pharmacology MH - *Potassium Channel Blockers MH - Rats MH - Rats, Wistar EDAT- 2000/01/29 09:00 MHDA- 2000/03/04 09:00 CRDT- 2000/01/29 09:00 PHST- 2000/01/29 09:00 [pubmed] PHST- 2000/03/04 09:00 [medline] PHST- 2000/01/29 09:00 [entrez] PST - ppublish SO - Mol Pharmacol. 2000 Feb;57(2):308-16.